Support Alert

Class 4 medicines defect information: Olmetec 20mg film-coated tablets

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class 4 medicines defect information drug alert for Olmetec 20mg film-coated Tablets. Daiichi Sankyo UK Limited is advising that there is an error on the blister foil of specific batches of Olmetec 20mg film-coated tablets.

Further details of the alert, the affected batches, and action to take are available on the MHRA website.